T

trifoil-imaging

lightning_bolt Market Research

TriFoil Imaging Company Profile



Background



Mission and Vision

TriFoil Imaging is dedicated to advancing preclinical imaging technologies to accelerate scientific breakthroughs in medicine and biology. The company focuses on providing innovative imaging solutions that enhance the understanding of complex biological processes.

Primary Area of Focus

Specializing in preclinical imaging systems, TriFoil Imaging offers multi-modality platforms that integrate various imaging techniques to provide comprehensive insights into biological phenomena.

Industry Significance

As a leader in the preclinical imaging industry, TriFoil Imaging plays a crucial role in advancing research by offering state-of-the-art imaging solutions that support the development of new medical treatments and therapies.

Key Strategic Focus



Core Objectives

  • Develop and manufacture advanced preclinical imaging systems.

  • Provide exceptional customer support and applications assistance.

  • Foster innovation in imaging technologies to meet evolving research needs.


Specific Areas of Specialization

  • Multi-modality imaging systems combining PET, SPECT, CT, and optical imaging.

  • Fluorescence Emission Computed Tomography (FLECT) for deep tissue imaging.


Key Technologies Utilized

  • InSyTe FLECT/CT system for 3D tomographic imaging.

  • Triumph II tri-modality imaging system (PET/SPECT/CT).

  • eXplore CT-120 In-vivo Micro CT scanner.


Primary Markets Targeted

  • Academic and research institutions.

  • Pharmaceutical and biotechnology companies.

  • Contract research organizations.


Financials and Funding



Funding History

TriFoil Imaging was acquired by Capital Resource Partners in 2013, transitioning from its previous status as a division of Gamma Medica.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly disclosed.

Notable Investors

Capital Resource Partners, a private equity firm, is the primary investor in TriFoil Imaging.

Intended Utilization of Capital

The capital has been utilized to enhance product development, expand market reach, and support ongoing research and development efforts.

Pipeline Development



Key Pipeline Candidates

  • InSyTe FLECT/CT system: A preclinical multi-modality imaging platform combining fluorescence tomography with X-ray CT for comprehensive 3D imaging.

  • Triumph II: A tri-modality imaging system integrating PET, SPECT, and CT technologies.

  • eXplore CT-120: An in-vivo micro CT scanner designed for high-quality, high-throughput imaging.


Stages of Development

  • InSyTe FLECT/CT: Commercially available and installed in various research facilities.

  • Triumph II and eXplore CT-120: Established products with a global installed base.


Target Conditions

These imaging systems are utilized in research related to oncology, cardiology, neurology, and other biomedical fields.

Anticipated Milestones

Ongoing product enhancements and the expansion of the installed base in academic and research institutions worldwide.

Technological Platform and Innovation



Proprietary Technologies

  • Fluorescence Emission Computed Tomography (FLECT): A technique for deep tissue imaging in small animals.

  • Multi-modality imaging systems integrating PET, SPECT, CT, and optical imaging.


Significant Scientific Methods

  • 3D tomographic imaging combining fluorescence tomography with X-ray CT.

  • High-throughput imaging capabilities for preclinical research.


AI-Driven Capabilities

Specific AI-driven capabilities are not detailed in the available information.

Leadership Team



Key Executives

  • Sam Kislevitz: Vice President of Operations. With over ten years of experience in clinical and preclinical engineering, Sam oversees research and development and manufacturing processes to ensure systems meet customer specifications.

  • Juan Maldonado: Procurement and Logistics Manager. With more than two decades of experience in procurement and logistics, Juan manages purchasing, inventory, and the implementation of cloud-based Material Requirements Planning (MRP) software.

  • David Kebede: Production Manager. With over nine years in research and development, David leads the manufacturing team to ensure production activities meet quality standards.

  • Hendrick Kuo: Chief Financial Officer. Hendrick manages financial operations, including budgeting, forecasting, and financial reporting.

  • Austin Moy: Director of Research. Austin leads research initiatives, focusing on the development of new imaging technologies and applications.

  • Jessica Sierra: Director of Marketing. Jessica oversees marketing strategies, brand development, and customer engagement efforts.


Competitor Profile



Market Insights and Dynamics

The preclinical imaging market is characterized by rapid technological advancements and increasing demand for high-resolution imaging systems. Key drivers include the need for non-invasive imaging techniques in drug development and disease research.

Competitor Analysis

  • Bruker Corporation: Offers a range of preclinical imaging systems, including MRI and mass spectrometry instruments.

  • Aspect Imaging Ltd: Specializes in compact MRI and NMR systems for preclinical and clinical imaging applications.

  • PerkinElmer, Inc.: Provides imaging systems and reagents for preclinical research, including optical and nuclear imaging modalities.

  • Mediso Ltd.: Develops multi-modality imaging systems, including PET/SPECT/CT and MRI scanners.


Strategic Collaborations and Partnerships

TriFoil Imaging has established collaborations with research institutions and distributors to expand its global presence and enhance product offerings. Notable installations include the Latvian Institute of Organic Synthesis and the Institute of Cytology and Genetics in Russia.

Operational Insights

TriFoil Imaging differentiates itself through its multi-modality imaging systems, offering comprehensive solutions that integrate various imaging techniques into a single platform. This approach provides researchers with versatile tools for in-depth biological studies.

Strategic Opportunities and Future Directions

The company aims to continue expanding its product portfolio, focusing on enhancing imaging capabilities and integrating advanced technologies to meet the evolving needs of the research community. Opportunities include developing AI-driven imaging solutions and exploring new applications in personalized medicine.

Contact Information



Official Website

TriFoil Imaging's official website provides detailed information about products, services, and corporate news.

Social Media Profiles

  • LinkedIn: TriFoil Imaging corporate profile.

  • Twitter: Official company updates and news.


Headquarters Location

Chatsworth, California, United States
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI